Showing results (231-240 of 329) with videos related to
Sort By:
Pageof 33
Biochemical and Biophysical Research Communications|August 17, 1999
Tryptophanless recombinant horseradish peroxidase: stability and catalytic propertiesI G Gazaryan, T A Chubar, O V Ignatenko, et al.Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1997
[Use of piperacillin/tazobactam as empirical monotherapy in the treatment of bacterial infections in a resuscitation department]S V Iakovlev, T V Shakhova, L I Dvoretskiĭ, et al.Bulletin of Experimental Biology and Medicine|April 11, 2023
Online Service with Automated Interpretation of Sequencing Data and Prediction of Pyrazinamide Resistance in Mycobacterium tuberculosisV V Sinkov, I G Kondratov, O B Ogarkov, et al.Klinicheskaia Laboratornaia Diagnostika|March 20, 2014
[The express diagnostic of microorganisms affecting respiratory tract of patients with mucoviscidosis]O L Voronina, M S Kunda, E I Aksenova, et al.Bulletin of Experimental Biology and Medicine|July 3, 2024
Analysis of the Diversity and Functional Potential of Bacterial Communities in TuberculomasE A Orlova, O B Ogarkov, I G Kondratov, et al.Journal of Drug Targeting|October 20, 2021
Nanoliposomes as drug delivery systems: safety concernsYu A Tereshkina, T I Torkhovskaya, E G Tikhonova, et al.International Journal of Molecular Sciences|December 17, 2024
Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma TreatmentAlina S Nazarenko, Alena O Shkirdova, Ekaterina A Orlova, et al.Kardiologiia|August 5, 2024
[Evaluation of the Functional Reserve and Exercise Tolerance in Patients with CHF in Clinical Trials (Consent Document of the Editorial board of the Journal of Cardiology, the Board of the Society of Specialists in Heart Failure (SSHF) and Working Group "Non-drug treatment methods" of SSHF)]Yu L Begrambekova, G P Arutynov, M G Glezer, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2009
[MRI-parameters of frontal lobes in schizophrenia: correlations with the level of autoantibodies to nerve growth factor in the blood serum]I V Shcherbakova, N N Efanova, V A Orlova, et al.Pharmaceutics|October 27, 2022
Chlorin e6 Phospholipid Delivery System Featuring APN/CD13 Targeting Peptides: Cell Death Pathways, Cell Localization, In Vivo BiodistributionYulia A Tereshkina, Lyubov V Kostryukova, Elena G Tikhonova, et al.Pageof 33